Hsp90: the vulnerable chaperone
Authors:
- Gabriela ChiosisGCGabriela Chiosis
- Maria VilenchikMVMaria Vilenchik
- Joungnam KimJKJoungnam Kim
- David SolitDSDavid Solit
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 9 (20) , 881-888
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Hsp70 and Hsp90—a relay team for protein folding2004
- Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 IsoformsChemistry & Biology, 2004
- Therapeutic and diagnostic implications of Hsp90 activationTrends in Molecular Medicine, 2004
- A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitorsNature, 2003
- A Nucleotide-dependent Molecular Switch Controls ATP Binding at the C-terminal Domain of Hsp90Journal of Biological Chemistry, 2002
- HSP90 as a new therapeutic target for cancer therapy: the story unfoldsExpert Opinion on Biological Therapy, 2002
- The Heat Shock Protein 90 Antagonist Novobiocin Interacts with a Previously Unrecognized ATP-binding Domain in the Carboxyl Terminus of the ChaperoneJournal of Biological Chemistry, 2000
- Disruption of Hsp90 Function Results in Degradation of the Death Domain Kinase, Receptor-interacting Protein (RIP), and Blockage of Tumor Necrosis Factor-induced Nuclear Factor-κB ActivationJournal of Biological Chemistry, 2000
- Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and GeldanamycinJournal of Medicinal Chemistry, 1999
- Geldanamycin-Induced Destabilization of Raf-1 Involves the ProteasomeBiochemical and Biophysical Research Communications, 1997